| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $985.0M | -10.3% |
| Cost of Revenue | $57.8M | +0.8% |
| Gross Profit | $368.9M | -10.1% |
| R&D Expense | $55.6M | +5.1% |
| SG&A Expense | $152.4M | -0.7% |
| Operating Income | -$32.8M | -507.9% |
| Interest Expense | $26.0M | -44.5% |
| Pre-tax Income | -$54.9M | -165.1% |
| Income Tax | $133.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $298.8M | +19.0% |
| Accounts Receivable | $83.1M | -14.9% |
| Current Assets | $414.0M | +10.6% |
| Total Assets | $1.20B | -7.7% |
| Current Liabilities | $82.5M | -69.9% |
| Long-term Debt | $813.5M | +70.1% |
| Total Liabilities | $991.4M | +16.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | -$27.9M | -376.9% |
| Financing Cash Flow | $32.5M | +151.4% |
| +1077.4% |
| Net Income | -$188.0M | -371.9% |
| EPS (Basic) | -$14.69 | -380.3% |
| EPS (Diluted) | -$14.69 | -390.9% |
| Stockholders' Equity |
| $207.9M |
| -53.6% |